Last Updated on April 2, 2025 by The Health Master
Drug alert
Drug alert: Download the list of NSQ samples for February 2025, the link is given below: 103 drug samples declared as not of standard quality (NSQ), nationwide.
NSQ Lists are given below the article
Out of these 103 samples, 47 were declared NSQ by CDSCO and 56 were declared NSQ by various STATES across India.

Details of the NSQ samples declared by STATES is as under:
Sr. | Name of STATES | Number of NSQ samples declared |
1 | Kerala | 21 |
2 | Puducherry | 13 |
3 | Telangana | 11 |
4 | J&K | 6 |
5 | Tripura | 4 |
6 | West Bengal | 1 |
Total | 56 |
Drug alert: Previous months
January 2025: 145 drug samples declared as NSQ, out of these 145 samples, 52 were declared NSQ by CDSCO and 93 were declared NSQ by various STATES across India.
December 2024: 135 drug samples declared as NSQ, out of these 135 samples, 51 were declared NSQ by CDSCO and 84 were declared NSQ by various STATES across India.
November 2024: 111 drug samples declared as NSQ, out of these 111 samples, 41 were declared NSQ by CDSCO and 70 were declared NSQ by various STATES across India.
October 2024: 90 drug samples declared as NSQ, out of these 90 samples, 56 were declared NSQ by CDSCO and 34 were declared NSQ by various STATES across India.
September 2024: 67 drug samples declared as NSQ, out of these 67 samples, 49 were declared NSQ by CDSCO and 18 were declared NSQ by various STATES across India.
August 2024: 59 drug samples declared as NSQ, out of these 59 samples, 48 were declared NSQ by CDSCO and 11 were declared NSQ by various STATES across India.
July 2024: 70 drug samples declared as NSQ, out of these 70 samples, 57 were declared NSQ by CDSCO and 13 were declared NSQ by various STATES across India.
June 2024: 61 drug samples declared as NSQ, out of these 61 samples, 31 were declared NSQ by CDSCO and 30 were declared NSQ by various STATES across India.
May 2024: 52 drug samples declared as NSQ, out of these 52 samples, 39 were declared NSQ by CDSCO and 13 were declared NSQ by various STATES across India.
April 2024: 50 drug samples declared as NSQ, out of these 50 samples, 33 were declared NSQ by CDSCO and 17 were declared NSQ by various STATES across India.
March 2024: Total 931 samples were tested. 864 samples were declared as of standard quality. 66 samples were declared as not of standard quality, one misbranded and none spurious.
February 2024: Total 1167 samples were tested. 1018 were declared as of standard quality. 58 samples were declared as not of standard quality, none misbranded and two spurious.
The samples were withdrawn by the officers of CDSCO and State FDAs, and tested in the drug testing laboratories, i.e CDLs, CDTLs, and RDTLs, in Kolkata, Mumbai, Hyderabad, Chandigarh, Indore, Guwahati and State Govt Drug Testing Laboratories.
Drug alert: 135 drug samples declared as NSQ in December 2024
Drug alert: 111 drug samples declared as NSQ in November 2024
Drug alert: 90 drug samples declared as NSQ in October 2024
Drug alert: 67 drug samples declared as NSQ in September 2024
Drug alert: 59 drug samples declared as NSQ in August 2024
Drug alert: 70 drug samples declared as NSQ in July 2024
Drug alert: 61 drug samples declared as NSQ in June 2024
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
Procedure to obtain license for Commercial Testing Laboratories
Latest Notifications: Testing Laboratories
Commercial Testing Laboratories
Commercial Testing Laboratories: Procedure
Updated list of Medical Device Testing Laboratories (MDTLs)
List of Laboratory Instruments for Pharma & Cosmetics Industry
Calibration of Laboratory Instruments
NABL: List of NABL Accredited Testing Laboratories
NABL 164 released : Guidelines for Inter-laboratory comparison
NABL releases NABL 136: specific criteria for X-Ray equipment
NABL 126: Specific criteria for calibration of Medical Devices
Laboratory Waste Management, Types and Its Disposal
NABL certification procedure for Laboratories
Quality Assurance Vs Quality Control in the Pharma Industry
NABL certification for Laboratories: Let’s understand
Major FDA audit findings about Equipment and Instruments
Equipment and Instruments: Maintenance, difference and importance in the Pharma Industry
Upcoming events: Pharma, Cosmetics, Homoeopathy & Medical Devices
Cosmetics Testing in India: A Comprehensive Guide
Difference between Validation and Calibration in the Pharma Industry
Calibration of Laboratory Instruments
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Duties and responsibilities of QA person in Pharma Industry
Dissolution test: Importance in Pharma Industry
Licensing procedure for manufacturing of Drugs
Procedure to obtain license for manufacturing of Cosmetics
Procedure to obtain license for manufacturing of Homoeopathic Medicines
Procedure to obtain license for manufacturing of Medical Devices
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
Procedure to obtain license for Blood Centre (Blood Bank)
Procedure to obtain license for Commercial Testing Laboratories
NPPA revised Ceiling price of 748 scheduled formulations: March 2025
Key Notes on Revised Schedule M: API Part-2
New prices of Coronary Stents in India effective from April 2025
New Boilers Bill 2024: A Safety Net for Pharma Industry
CDSCO: Apply online for Schedule M Extension by May 2025
USFDA inspection: At Alembic with zero observations
Karnataka streamlines Essential Narcotic Drugs
Tentative USFDA approval granted for Amifampridine Tablets
List of Drugs declared as NSQ by CDSCO for the Month of February– 2025.
As part of the continuous regulatory surveillance, drug samples are picked from sales/distribution point, analyzed and list of Not of Standard Quality (NSQ) drugs are displayed on CDSCO portal on monthly basis. The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market.
A. CDSCO/Central Laboratories | |||||||
S.No | Product/Drug Name | Batch No. | Manufactur ing Date | Expiry Date | Manufactured By | NSQ Result | Reported by CDSCO Laboratory |
1. | Compound Sodium Lactate Injection IP (Ringer Lactate Solution for Injection) | DCSL3021 | 11/2023 | 10/2026 | M/s. Eurolife Healthcare Pvt. Ltd., K.No-520, Bhagwanpur, Roorkee-247667, Uttarakhand | Particulate Contamination, Bacterial endotoxin test, Sterility and Description | CDL, Kolkata |
2. | Rabeprazole Tablets IP 20 mg | MT-24E30 | 05/2024 | 10/2025 | M/s. Martin & Brown Bio- Sciences Pvt. Ltd. K. No. 918/419, Malkumajra, Nalagarh Road, Baddi, Distt. Solan (H.P.) 173205 | Related Substances, Dissolution (Buffer Stage) and Assay of Rabeprazole Sodium | CDL, Kolkata |
3. | Haloperidol Injection IP (Radipace) | L2403/2 | 03/2024 | 02/2026 | M/s. SBS Biotech, Mouza Rampur Jattan, Nahan Road, Kala Amb, District Sirmour (H.P.) | Particulate matter and Description | CDL, Kolkata |
4. | Rabeprazole Sodium Injection IP | MD23H10 | 08/2023 | 07/2025 | M/s. Martin & Brown Bio- Sciences K. No. 918/419, Malkumajra, Nalagarh Road, Baddi, Dist- Solan (H.P) 173205 | pH, Clarity of Solution, Particulate matter, Related Substances and Assay of Rabeprazole sodium | CDL, Kolkata |
5. | Disinfectant Fluid Phenolic Type (Konark Super Phenyle) | KSP-355 | 12/2024 | 05/2026 | M/s. Teedeecol (India), Hari Om Complex, Behind Sri Krishna Goshala, Bangali Para, Jharsuguda -768201 Odisha | Grade and Germicidal Value | CDL, Kolkata |
6. | Levosalbutamol Sulphate, Ambroxol Hydrochloride & Guaiphenesin Syrup, (Blurex-LS Syrup) | TBHX0448 | 05/2024 | 04/2026 | M/s. Three B Healthcare Ltd., Opp. Dental college, Rampur Road, Paonta Sahib, Distt- Sirmour (HP)-173025 | Assay of Ambroxol Hydrochloride | CDL, Kolkata |
7. | Adrenaline Bitartrate Injection I.P. 1ml | HIAN24005A | 09/2024 | 08/2025 | M/s. Health Biotech Ltd. Village Sandoli, Nalagarh Road, Baddi, Distt. Solan (HP) 173205, India | Appearance of solution, Particulate matter and Description | CDL, Kolkata |
8. | Aminophylline Injection I.P .10 ml | MA23L108 | 12/2023 | 11/2025 | M/s. Martin and Brown Biosciences K.No-918/419, Malkumajra, Nalagarh Road, Baddi, Dist-Solan (H.P.)- 173205 | Particulate matter, Assay of Ethylenediamine and Theophylline and Description | CDL, Kolkata |
9. | Bupivaaine Hydrochloride in Dextrose Injection USP | HIBU23010 | 09/2023 | 08/2025 | M/s Health Biotech Ltd., Vill- Sandoli, Nalagarh Road, Baddi, Dist- Solan, HP-173205 | Particulate Matter in Injection and Description | CDL, Kolkata |
10. | Compound Sodium Lactate Injection I.P. (Ringer Lactate Solution for Injection ) (Hi- Ring-RL) | F41746 | 11/2024 | 10/2027 | M/s. HIGGS HEALTHCARE , Khasra No-480/1, Bhatolikalan Baddi, H.P. | Bacterial endotoxins | CDL, Kolkata |
11. | Compound Sodium Lactate Injection I.P. (Ringer Lactate Solution for Injection ) (Hi-Ring-RL ) | F41799 | 11/2024 | 10/2027 | M/s. HIGGS HEALTHCARE , Khasra No-480/1, Bhatolikalan Baddi, H.P. | Bacterial endotoxins | CDL, Kolkata |
12. | COMPOUND SODIUM LACTATE INJECTION IP 500 ml. (Ringers Lactate I.P. ) (RL) | 03BF2442 | 03/2024 | 02/2027 | M/s.Paschim Banga Pharmaceuticals (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, Tin Mile Hat, Sonapur Hat, PS-Chopra, Dist-Uttar Dinajpur-733214 (W.B.) | Bacterial endotoxins | CDL, Kolkata |
13. | Ciprofloxacin Injection IP (0.2%w/v) | 09AF0075 | 05/2023 | 04/2026 | M/s.Paschim Banga Pharmaceuticals (A Unit of Farista Vanijya Pvt. Ltd), NH- 31, Tin Mile Hat, Sonapur Hat, P.S.-Chopra, Dist-Uttar Dinajpur-733214 (WB) | Particulate contamination | CDL, Kolkata |
14. | Carboxymethylcellulose Sodium Eye Drops IP 10 ml | MO24H19 | 08/2024 | 07/2026 | M/s. Martin & Brown Bio- Sciences Pvt. Ltd. K. No. 918/419 Malkumajra, Nalagarh Road, Baddi, Distt. Solan (HP) 173205 | pH and Sterility | CDL, Kolkata |
15. | Drotaverine Hydrochloride Tablets 40 mg. (Dratovis-40 ) | 12680 | 01/2024 | 12/2026 | M/s. Syncom Formulations (India) Ltd., Factory-256-257, Sector-1, Pithampur (Dhar )- 454775 , Madhya Pradesh India | Assay of Drotaverine Hydrochloride | CDL, Kolkata |
16. | Azithromycin Oral Suspension I.P. (Azysafe Liquid-100 ) | AZ1-206 | 10/2023 | 03/2025 | M/s. Overseas Healthcare Pvt. Ltd., 335KM Milestone, National Highway No.1, P.O. Box No.-25, Phillaur-144410 (Pb) | Uniformity of Volume | CDL, Kolkata |
17. | Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D- Pantothenate Syrup (B- Complex Syrup), | BOB-2423 | 06/2024 | 11/2025 | M/s. Apple Formulations Pvt. Ltd., Plot no. 208, Kishanpur, Roorkee-247667 (U.K.) | Assay of Calcium D-Pantothenate | CDL, Kolkata |
18. | Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D- Pantothenate Syrup (B- Complex Syrup) | BOB-2424 | 06/2024 | 11/2025 | M/s. Apple formulations Pvt. Ltd. Plot no. 208, Kishanpur, Roorkee-247667 (U.K.) | Assay of Calcium D-Pantothenate | CDL, Kolkata |
19. | Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D- Pantothenate Syrup (B- Complex Syrup) | BOB-2438 | 06/2024 | 11/2025 | M/s. Apple formulations Pvt. Ltd. Plot no. 208, Kishanpur, Roorkee-247667 (U.K.) | Assay of Vitamin B12 | CDL, Kolkata |
20. | Phenytoin Sodium Injection USP | PTS-225A | 05/2024 | 04/2026 | M/s. Pushkar Pharma, Kheri, Kala-Amb-173030 (H.P.) | Alcohol Content and Propylene Glycol content | CDL, Kolkata |
21. | Rabeprazole Sodium Injection IP | MD24E30 | 05/2024 | 04/2026 | M/s. MARTIN & BROWN BIO- SCIENCES PVT. LTD., K.No- 918/419, Malkumajra, Nalagarh Road, Baddi, Dist- Solan (H.P.)-173205 | pH, Clarity of Solution, Particulate matter and Description | CDL, Kolkata |
22. | Polywin Vitamin B Complex Injection (Polywin) | MA24H16 | 08/2024 | 01/2026 | M/s. MARTIN & BROWN BIO- SCIENCES PVT. LTD., K.No- 918/419, Malkumajra, Nalagarh Road, Baddi, Dist- Solan (H.P.)-173205 | Extractable volume, Particulate matter, Assay of Riboflavin Sodium Phosphate and Description | CDL, Kolkata |
23. | Sitagliptin Phoshpate Tablets I.P. (50 mg) | MT243714 | 11/2024 | 10/2026 | M/s. Mascot Health Series Pvt. Ltd., Plot No. 79,80, Sec-6A, IIE, Sidcul, Haridwar 249403 | Assay of Sitagliptin Phosphate | CDL, Kolkata |
24. | Vitamin B1, Vitamin B2, Nicotinamide, Vitamin B6, Vitamin B12 & Calcium D- Pantothenate Syrup (B- Complex Syrup) | BOB-2452 | 06/2024 | 11/2025 | M/s. Apple formulation Pvt. Ltd., Plot no. 208, Kishanpur, Roorkee-247667 (U.K.) | Assay of Vitamin B12 | CDL, Kolkata |
25. | Sucralfate USP | LSU2409105 | 09/2024 | 08/2029 | M/s. LEGEND INDUSTRIES, Unit-II, Plot No. C1/200-201/4, Phase-II, Opp. Encore Ltd., Naroda, G.I.D.C., Ahmedabad- 382 330 | Spurious Identification and Assay of Sucralfate | CDL, Kolkata |
26. | Wholeshield Refire Premium Herbal Blend Capsule | EAHC24021 | 09/2024 | 08/2027 | M/s. Aeron Lifescience Pvt. Ltd.D 152 & 153 Zaveri Com. Co.Op, Road Number 11, Kathwada GIDC, Ahmedabad, Gujarat 382430, | Assay | CDL, Kolkata |
27. | Wholeshield Refire Premium Herbal Blend Capsule | EAHC24020 | 09/2024 | 08/2027 | M/s. Aeron Lifescience Pvt. Ltd.,D 152 & 153 Zaveri Com. Co.Op, Road Number 11, Kathwada GIDC, Ahmedabad, Gujarat 382430 | Assay | CDL, Kolkata |
28. | Co-trimoxazole Tablets I.P. (D.S.= Double Strength) | PT30119 | 05/2023 | 04/2025 | OMEGA PHARMA,, Khasra No.482, Village Saliyar, Roorkee-247667, Distt. Haridwar. (Uttarakhand) | Dissolution (Sulphamethoxazol e and Trimethoprim) | RDTL, Guwahati |
29. | Albendazole Tablets IP 400 mg | LMT241138 | 10/2024 | 09/2026 | Life Max Cancer Laboratories, Plot No. 106 & 106 A, Sector6A, IIE, SIDCUL, Haridwar249403 (U.K) | “Dissolution” of Albendazole | RDTL, Guwahati |
30. | Glimepiride Tablets I.P. 1mg | GLI10823 | 05/2023 | 04/2025 | KARNATAKA ANTIBIOTICS & PHARMACEUTICALS LIMITED, Arka The Business Centre, Plot No. 37, Site No. 34/4, NTTF Main Road, Peenya Industrial Area, 2nd Phase, Bengaluru-560058, INDIA. | Dissolution | RDTL, Guwahati |
31. | Linezolid Tablets I.P. 600 mg. (ALINO-600 Tablets) | VLB-GT-2500 | 12/2023 | 11/2025 | Vee Laboratories,, Village Kalier, Subathu, RoadSaproon (Post Office) Solan173211, Himachal Pradesh | Dissolution | RDTL, Guwahati |
32. | Norfloxacin Tablets I.P. 400mg. | NFXT-1002 | 06/2023 | 05/2026 | WINGS BIOTECH LLP, 43 & 44, HPSIDC, Industrial Area, Baddi – 173205 (H.P.) | Dissolution | RDTL, Guwahati |
33. | Nitrofurantoin Tablets IP 100mg | T-2485 | 11/2023 | 10/2025 | Jackson Laboratories Pvt.Ltd, 22-24, Majitha Road, Bye Pass, Amritsar-143 001(India) | Dissolution | RDTL, Guwahati |
34. | Amoxycillin & Clavulanate Potassium for Oral Suspension I.P. 3.6gm/30ml | 724-37 | 02/2024 | 01/2026 | M/s. ZEE LABORATORIES LTD, Behind 47, Industrial Area, Paonta Sahib-173025 | Identification and Assay/Content of Clavulanic Acid | RDTL, Guwahati |
35. | Telmisartan Tablets IP 40mg (Savtel 40 Tablets) | PT-40584 | 02/2024 | 01/2026 | Pharmaroots Healthcare, Khasra No. 411, Village Tipra, P.O. Barotiwala, Tehsil Baddi, Distt. Solan, H.P. | Dissolution | RDTL, Guwahati |
36. | Telmisartan Tablets IP (TELMOPI-40 Tablets) | 23I-T2013 | 12/2023 | 11/2025 | M/s. Orison Pharma International, Vill. Khari, Mauza Ogli, Kala Amb, Distt. Sirmour – 173030 (H.P.) | Dissolution | RDTL, Guwahati |
37. | Paracetamol & Diclofenac Sodium Tablets I.P. (IG Pyrin) | IGN-2602 | 05/2023 | 04/2026 | I.G. PHARMA LTD., 12.4KM, MEERUT ROAD, ROORKEE, DIST. HARIDWAR (UK) | Dissolution of Paracetamol & Diclofenac Sodium | RDTL, Guwahati |
38. | Iron Sucrose Injection USP 100 mg/ 5 ml | 23IS10 | 12/2023 | 11/2025 | Sai Parenterals Limited, D1 & D4, Survey No. 280, Phase-V, Ida, Jeedimetla, Hyderabad- 500055, Telangana, India. | “pH”, “Alkalinity” and “Particulate Matter In Injection” | CDTL-Mumbai |
39. | Linezolid IV Injection 600 mg/ 300 ml (ABAZOLID) | A4544004 | 04/2024 | 03/2026 | Abaris Healthcare Pvt. Ltd., Survey No. 1407-11, Villate : Rajpur, Taluka : Kadi, Dist : Mehsana- 382740.Gujarat | “Related substances” | CDTL-Mumbai |
40. | Bacillus clausii Spores Suspension (Bactogermina Oral Suspension 2 Billion/ 5 ml) | AFL241415 | 10/2024 | 09/2026 | AARMED FORMULATIONS PVT. LTD., Survey No.431/2, Plot No.1, Steel Town, Moraiya, Tal. Sanand, Dist. Ahmedabad, (Gujarat) | Assay as “Viability” (Total viable count) | CDTL-Mumbai |
41. | Lignocaine Hydrochloride Gel IP 5 % w/v (30 g) | G407 | 09/2024 | 08/2026 | Gnosis Pharmaceuticals Pvt. Ltd., Nahan Road, Village Moginand, Kala- Amb Distt. Sirmour, H.P. – 173030. | “pH” | CDTL-Mumbai |
42. | Ferric Carboxymaltose Injection 500 mg/ 10 ml (For IV Injection / Infusion) | SVI-24171A | 08/2024 | 07/2026 | Sunvet Healthcare, Village Shambhuwala, Paonta Road, Distt. Sirmour (H.P.) 173001, | “Bacterial Endotoxins”, “Sterility” and “Assay” | CDTL-Mumbai |
43. | Ferric Carboxymaltose Injection 1 g,/ 20 ml (For IV Injection / Infusion) | SVI-24168B | 08/2024 | 07/2026 | Sunvet Healthcare, Village Shambhuwala, Paonta Road, Distt. Sirmour (H.P.) 173001, | “Bacterial Endotoxins”, “Sterility” and “Assay” | CDTL-Mumbai |
44. | Levocetirizine Dihydrochloride Tablets IP 5 mg (Alercet-5) | 2411110 | 11/2024 | 10/2026 | M/s. Brij Healthcare Pvt. Ltd, 51/10, G.I.D.C Esatae, Motipura, Himatnagar – 383001, Gujarat | Dissolution | CDTL, Indore |
45. | Clonazepam Tablets IP 0.5 mg (NOZIM-0.5) | DT40078 | 12/2024 | 11/2027 | M/s. Elikem Healthcare Private Limited, Plot/Survey No. 146, Near Sarbhara Beverages, Village – Borisana, Tal. – Kadi, Dist. – Mehsana – 382 715, Gujarat, India | Dissolution | CDTL, Indore |
46. | Aceclofenac, Paracetamol & Serratiopeptidase Tablets (Acemarc-SP Tablets) | MT-306 | 12/2024 | 11/2026 | M/s Maha Avtar, Health Care Pvt. Ltd., D-22, Sector-17, Kavi Nagar Indl.Area, GZB-201002 | Uniformity of weight | RDTL, Chandigarh |
47. | Sodium Bicarbonate Tablets U.S.P. 1000 mg (NABOSIS 1000 mg | T-2307270 | 07/2023 | 06/2025 | M/s. Rivpra Formulation Pvt. Ltd., Plot No. 8, Sector-6A, IIE SIDCUL, Haridwar-249 403 (U.K. | Description | CDTL, Hyderabad |
Not of Standard Quality (NSQ) drugs:
The drugs that fail to meet the quality standards or specifications are known as Not of Standard Quality (NSQ) drugs.
(Further, the term ‘standards of quality’ is defined under the Section 16 (1) (a) of Drugs & Cosmetics Act, 1940, that the ‘standards of quality’ mean that the drug complies with the standards set out in the Second Schedule of the said Act.)
List of Drugs declared as NSQ by STATES for the Month of February– 2025.
As part of the continuous regulatory surveillance, drug samples are picked from sales/distribution point, analyzed and list of Not of Standard Quality (NSQ) drugs are displayed on CDSCO portal on monthly basis. The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market.
B. State Laboratories | |||||||
S. No | Product/Drug Name | Batch No. | Manufact uring Date | Expiry Date | Manufactured By | NSQ Result | Reported by State Laboratory |
1. | Calcium & Vitamin D3 Tablets IP | PGT246 72 | 09/24 | 08/26 | Affy Parenterals Vill. Gullawala P.O Baddi Distt. Solan 173205 (HP) | The sample does not conform to the IP 2022 requirement with respect to uniformity of weights | Drug Testing Laboratory Srinagar (J&K) |
2. | Para 500 | NBRT- 018 | 05/23 | 04/26 | Laborate Pharmaceuticals India Ltd (Unit II) 31, Rajban Road Nariwala Paota Sahib (HP) Mfg For : GPP Axalade 101, Kohand –Assandh Road V.P.O Salwan Haryana -132046 | The sample does not conforms to the IP 2022 requirement w.r.t dissolution test | Drug Testing Laboratory Srinagar (J&K) |
3. | Phenytoin Tablets IP 100 mg | T-1150 | 04/24 | 03/26 | Jackson Laboratories Pvt Ltd 22-24, Majitha Road Bye Pass Amritsar – 143001 (India) | The sample does not conforms w.r.t the test for description | Modern Drug Testing Laboratory Kathua (J&K) |
4. | Telfine -CT | T-1150 | 01/24 | 12/25 | Cosmas Pharmacls Ltd. Buranwala Road Village Kotla P.O Barotiwala Solan (H.P) 174103 Mrk. By: NemaSis kabee Vakil Sahab Haveli Near Ansal Mall Bamba Mohalla Jodhpur India – 342001 | The sample does not conform w.r.t the Assay contents of Telmisartan and Chlorthalidone | Modern Drug Testing Laboratory Kathua (J&K) |
5. | Xorcid-O Suspension | LSF- B0656 | 07/23 | 06/25 | Spen Formulations Pvt Ltd Plot No. 123, Industrial Area , Mehatpur, Distt. Una-174315 (H.P) | Under Investigation / The sample is found spurious as the Assay contents of Sucralfate and Oxetacaine are found to be NIL and also fails in the test for Description | Modern Drug Testing Laboratory Kathua (J&K) |
6. | Cloprostenol Injection IP (Vet) (M Promate Injection) | I241020 | 10/24 | 09/26 | Monatt Biotech E-31, New Focal Point Bathinda – 151005 | Sheep Husbandry Supply / The sample is found spurious as the Assay contents of Cloprostenol Sodium I.P is found to be Nil and also fails in the Test for Sterility | Modern Drug Testing Laboratory Kathua (J&K) |
7. | MIDAZOLAM Injection IP | 24257 | 08/2024. | 07/2026. | M/s. T Walkers Pharmaceuticals Pvt Ltd, Gta No 285-B, Viii-Kasaramboli, Po Ambedvet, Tal- Mulshi, Dist Pune 411004 Maharashtra | NOT OF STANDARD QUALITY The sample Midazolam Injection I.P does not comply for Assay and pH parameters as per IP 2022. | State Lab, Drugs Control Laboratory,Telangana. |
8. | Zinc Sulphate 20mg Dispersible Tablets IP | T-15192 | 03/2023. | 02-2025. | Karnal Pharmaceuticals Pvt Ltd 38, Pharmacity, Selaqui, Dehradun,Uttarakhand-248 011 Uttarakhand | NOT OF STANDARD QUALITY The sample Zinc Sulphate 20 mg Dispersible Tablets IP does not comply disintegration test as per I.P 2022. | State Lab, Drugs Control Laboratory,Telangana. |
9. | Cefdoxi-CV-50 dry syrup Cefpodoxime & Potassium Clavulanate for Oral Suspension | CD0724 002F | 02/2024. | 07/2025. | Alencure Biotech Pvt Ltd Village: Nagal, Suketi road, P.O. Moginand, Kala Amb, Distt. Sirmour-173030 (HP) HIMACHAL PRADESH | NOT OF STANDARD QUALITY Description Dose Not complies– Orange -colored suspension, that is not uniformly resuspendable after reconstitution with the sterile water ampoule provided in the pack A clear phase separation is observed immediately after reconstitution. Additionally, the reconstituted suspension exhibits an obnoxious/ unacceptable odour.Assay Does Not Complies: The Assay content found is not within the prescribed limit. | State Lab, Drugs Control Laboratory,Telangana. |
10. | Amoxyheal-CV tablets Amoxycillin & Potassium Clavulanate Tablets I.P | TB2403 78A | 10/2024. | 09/2026. | Polestar power industries(Pharma division) Damuwala, Haripur road, Barotiwala, Baddi, Distt: Solan (H.P.)- 174 103 HIMACHAL PRADESH | NOT OF STANDARD QUALITY The sample failed with respect to the test for Unifarmity of Weight for tablets, as 6 out of twenty tablets fall outside the prescribed limit of 5 percent. | State Lab, Drugs Control Laboratory,Telangana. |
11. | Diclofenac Sodium tablets IP 50mg. | DT23- 38 | 12/2023. | 11/2025. | Leostar Healthcare Pvt. Ltd Sy No. 321, Plot No. 10, Biotect park phase- III, Genome valley, Karlapatla (V), Markook(M), Siddipet(Sist)502281, | NOT OF STANDARD QUALITY While opening the strip, it is found that the tablets are not in intact condition. Hence sample is of Not of Standard Quality with respect to Description test parameter.Disintegration test does not complies since the tablets disintegrated in acid medium completely. But as per IP the coating of the enteric coated should be in intact condition in acid medium. Hence sample is of Not of Standerd Quality with respect to Disintegration test parameter. | State Lab, Drugs Control Laboratory,Telangana. |
12. | RABISAP tablets Rabeprazole Gastro Resistant Tablets IP 20 mg | AST 24524 | 10/2024. | 09/2026. | AASSK Pharmaceuticals Pvt Ltd Plot NO.9 Dr .Ambedkar Street, Kozhumanivakkam, Mangadu,Chennai-600122. TAMIL NADU | NOT OF STANDARD QUALITY Sample does not complies in respect of Dissolution test as per IP | State Lab, Drugs Control Laboratory,Telangana. |
13. | Rabicy-20 Tablets Rabeprazole Tablets IP 20 mg | AT2403 4149 | 03/2024. | 02/2026. | Accura Care Pharmaceuticals Pvt Ltd ( A Venture of Biochemix grop (Agmp& ISO Certified Co) Vill. Mogin and Nahan Road Kala Amb.Dist Sirmour (H.P)173030 HIMACHAL PRADESH | NOT OF STANDARD QUALITY &MISBRADED Sample does not complies in respect of Dissolution test as per IPThe drug Rabeprazole Sodium is official in IP. But the product titile Rabeprazole Sodium IP is not mentioned on the product label. Hence the subject drug is Misbranded as per section 17 of Drugs & Cosmetics Act 1940, as it is not labeled in the prescribed manner | State Lab, Drugs Control Laboratory,Telangana. |
14. | ACEGLO tablets Aceclofenac and Paracetamol Tablets | ATG4I7 87 | 09/2024. | 08/2026. | Anrose pharma 147,Mauza Sansiwala ,Post :Barotiwala ,Tehsil – Kasauli ,Dist .Solan(H.P.)-173205 HIMACHAL PRADESH | MISBRANDED DRUG The drug product Aceclofenac and Paracetamol Tablets is official i.e. included in the Addendum 2024 to Indian Pharmacopoeia 2022 effective from 1st July, 2024-current edition of IP and as required as per Second Schesule of the Drugs and Cosmetics Act, 1940. The said drug product shall comply with the standards set out in the Indian Pharmacopoeia .But the designation IP in conjunction with the official title Aceclofenac and Paracetamol tablets on the label of the drug product was not menttioned as an indication that the drug product purports to comply with IP standards. Hence the drug product shall be deemed to be Misbranded Drug as per Secton 17 of Drugs and Cosmetics Act, as it is not labeled in the prescribed manner. | State Lab, Drugs Control Laboratory,Telangana. |
15. | Amrox-LS syrup Levosalbutamol Sulphate, Amborxol Hydrochloride & Guaipenesin syrup | AJLH24 051 | 06/2024. | 05/2026. | M/s. Leeford Healthcare Ltd. Plot No. 88-B, EPIP, Phase – II, Village- Thana, Baddi, Distt. Solan (H.P) 173205 HIMACHAL PRADESH | MISBRANDED DRUG In the composition the label should be mentioned as Levosalbutamol Sulphate IP equivalent to Levosalbutamol. But the label is mentioned as only Levosalbutamol Sulphate IP, equivalent to Levosalbutamol as not mentioned. Hence it is a Misbranded drug as per section 17 of Drugs and Cosmetics Act, as it is not labeled in the prescribed manner. | State Lab, Drugs Control Laboratory,Telangana. |
16. | Cefixime Dispersible Tablets IP 100 mg | oo84 | 10/2024. | 03/2026. | Stride Organics Private Limited SY.No.265/P,Kondapur(Vill.),Ghatkes ar,Medchal District(T.S.) Telangana | MISBRANDED DRUG The sample is deemed to be misbranded as it is labeled only with the words approved colours used but fails to include the common name of the color on the label, as required by Rule 127(2) of the Drugs Rules, 1945.Additionally, the label does not state that the tablets should be dispersed in water immediately before use, as required by the IP 2022 monograph for Cefixime Dispersible tablets. Hence, the drug is deemed Misbranded under section 17 of the Drug and Cosmetics Act, 1940 as it is not labeled in the prescribed manner. | State Lab, Drugs Control Laboratory,Telangana. |
17. | Moovrun tablets Diclofenac Sodium and Paracetamol tablets | DFP- 2403 | 01/2024. | 12/2025. | Concord Drugs Ltd . Sy no.249 ,Brahmanapally ,R.R.(DT),T.S.501505 Telangana | MISBRANDED DRUG The drug product Diclofenac sodium and Paracetamol tablets is offcially included in the current edition of Indian Pharmacopoeia IP 2022 and as required as per second schedule of the Drugs and Cosmetics Act, 1940 the said Product shall comply with the standards set out in the Indian Pharmacopoeia. But the designation IP in conjunction with the offcial title Diclofenac sodium and Paracetamol tablets on the label of the drug product was not mentioned as an indication that the drug product purports to comply with the IP satadards. Hence the drug product shall deemed to be MISBRANDED DRUG as per section 17 of Drugs and Cosmetics Act, 1940 as it is not labelled in the prescribed Manner. | State Lab, Drugs Control Laboratory,Telangana. |
18. | Sodium Hypochlorite 5% (NaOCL) | NSSH1 0 | 01/2024. | 12/2025. | Neucleus Scientific, Azara, Guwahati – 781017 (Assam) | The Sample does not conform to standard in respect of the test “Assay” performed. | State Drugs Testing Laboratory, Agartala, Tripura. |
19. | URINIF-SR (Nitrofurantoin Sustained Release Tablets I.P. 100 mg | USR- 186 | 11/2024. | 10/2026. | Overseas Health Care Pvt. Ltd., 335 km, Milestone, National Highway No. 1, P.O. Box No. 25, Philaur – 144410, Punjab. | The sample does not conform to standard in respect of the test for “Dissolution” test performed. | State Drugs Testing Laboratory, Agartala, Tripura. |
20. | Glitel M1 (Glimepride & Metformin Hydrochloride Prolonged Releasre Tablets IP) | LGN05/ 186/08 | 05/2024. | 04/2026. | Logos Pharma, Village MaissaTibba, Tehsil Nalagarh, Dist. Solan (H.P) – 174101. | The sample does not conform to Standard in respect of the tests for “Assay, Dissolution & Uniformity of content for Glimepiride” performed. | State Drugs Testing Laboratory, Agartala, Tripura. |
21. | Glitel M2 (Glimepride & Metformin Hydrochloride Prolonged Releasre Tablets IP) | LGM09/ 237/11 | 09/2024. | 08/2025. | Logos Pharma, Village MaissaTibba, Tehsil Nalagarh, Dist. Solan (H.P) – 174101. | The sample does not conform to Standard in respect of the tests for “Assay, Dissolution & Uniformity of content for Glimepiride” performed. | State Drugs Testing Laboratory, Agartala, Tripura. |
22. | Amoxycillin & Potassium Clavulanate Tab I.P. | APTD- 002 | 12/2024. | 05/2026. | M/s. Standard Pharmaceuticals Ltd., Serampore-712203, West Bengal | Does not conform to I.P. | State Drugs Testing Laboratory, Kolkata, West Bengal. |
23. | Telmisartan Tab IP 40 mg [Telmasil-40] | TBS 034 | 45352 | 02/26 | RTN Pharma, Sy. No. 675/2, Plot No.15, 17, 18 & 19 Bharathiyar Nagar, Avalapalli Road, Hosur- 635 109 , Tamil Nadu | It fails the test ‘Dissolution’ Specified in the laboratory protocol as per IP | Drugs Testing Laboratory Thiruvananthapuram |
24. | Paracetamol Tab IP 500 mg | PAK 551 | 06/23 | 05/26 | Healer’s Lab Unit II, Plot No. 33, H.P.S.I.D.C, Extn. Baddi, Distt-Solan (H.P) | It fails the test ‘Dissolution’ Specified in the laboratory protocol as per IP | Drugs Testing Laboratory Thiruvananthapuram |
25. | Paracetamol Tab IP [Parayes -500 ) | 423- 1582 | 09/23 | 08/26 | Zee Laboratories Ltd, behind 47, Industrial Area, Paonta Sahib- 173 025 | It fails the test ‘Dissolution’ Specified in the laboratory protocol as per IP | Drugs Testing Laboratory Thiruvananthapuram |
26. | Fevanex Rapid – 650[ Paracetamol Tab IP 650 mg] | SRGT- 24471 | 08/24 | 07/26 | SPAS REMEDISE Vill, bersan P.O, Lodhi Majra, Tehsil Baddi, Dist.Solan (HP) 173 205 | It fails the test ‘Dissolution’ Specified in the laboratory protocol as per IP | Drugs Testing Laboratory Thiruvananthapuram |
27. | Vitamin B Complex Tablets N.F.I | VBT241 6 | 03/24 | 02/26 | Modern Laboratories 45-47, Sector D- 2, Industrial area, Sanwer Road, Indore (MP) 452 015 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol. | Drugs Testing Laboratory Thiruvananthapuram |
28. | Liquid Paraffin IP | 163 | 03/24 | 08/26 | Medi smith Pharma Lab, #20A 1 st phase, KIADB, Mysore Road Kumbalagodu, Bangalore- 560074 | It fails the test ‘Light Absorption’ specified in the laboratory protocol as per IP | Drugs Testing Laboratory Thiruvananthapuram |
29. | Vitamin B Complex Tablets N.F.I | VBT 2468 | 05/24 | 04/26 | Modern Laboratories 45-47, Sector D- 2, Industrial area, Sanwer Road, Indore (MP) 452 015 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol. | Drugs Testing Laboratory Thiruvananthapuram |
30. | Isosorbide Dinitrate Tablets IP [ISOMIC 10] | PT- 42968 | 08/24 | 07/26 | Pharmaroots Healthcare, Khasra No. 411, Village Tipra.P.O, Barotiwala, Tehsil ,dist. Soaln (HP) | The sample does not conform to identification test for Isosorbide Dinitrate as per IP. Hence the sample is spurious and declared as Not of Standard Quality | Drugs Testing Laboratory Thiruvananthapuram |
31. | Vitamin B Complex Tablets N.F.I | VBT 2415 | 03/24 | 02/26 | Modern Laboratories 45-47, Sector D- 2, Industrial area, Sanwer Road, Indore (MP) 452 015 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol. | Drugs Testing Laboratory Thiruvananthapuram |
32. | Vitamin B Complex Tablets N.F.I | VBT 2417 | 03/24 | 02/26 | Modern Laboratories 45-47, Sector D- 2, Industrial area, Sanwer Road, Indore (MP) 452 015 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol. | Drugs Testing Laboratory Thiruvananthapuram |
33. | Vitamin B Complex Tablets N.F.I | VBT 2414 | 03/24 | 02/26 | Modern Laboratories 45-47, Sector D- 2, Industrial area, Sanwer Road, Indore (MP) 452 015 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol. | Drugs Testing Laboratory Thiruvananthapuram |
34. | Folic Acid Tablets IP 5 mg [Foldivit] | FTV240 04 | 06/24 | 05/26 | Danish Healthcare (p) Ltd, 76/27-28, Industrial Estate, Maxi Road, Ujjain, 456010, MP | It fails the test ‘Dissolution’ Specified in the laboratory protocol as per IP | Drugs Testing Laboratory Thiruvananthapuram |
35. | Mydew Ultra Syndet Bar | 2387 | 01/24 | Best before 36 months from the date of Mfg. | Jain Soap, 39/A, Devam Estate, Gandhi Nagar, Gujarat | The sample does not conform to the test pH as per manufacturer’s specification for Mydew Ultra Syndet Bar as specified in the Laboratory Protocol | Drugs Testing Laboratory Thiruvananthapuram |
36. | Acetazolamide Tablets IP 250 mg | T 240840 | 08/24 | 07/27 | Micron Pharmaceuticals, 2117, A-2, PhaseIII, GIDC, Vapi- 396 195 | It fails the test ‘Dissolution’ Specified in the laboratory protocol as per IP | Drugs Testing Laboratory Thiruvananthapuram |
37. | Clopidogrel Tab IP 75 mg | D 2720/24 -25 | Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14 | It fails the test ‘Dissolution’, ‘Assay’ and descriptive part for tablets specified above as per IP | Drugs Testing Laboratory Thiruvananthapuram | ||
38. | Cefixime Oral Suspension IP 100 mg/5ml | D2852/2 4-25 | Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14 | It fails the test ‘Assay’ and ‘Descriptive part’ for oral powders specified above as per IP | Drugs Testing Laboratory Thiruvananthapuram | ||
39. | Vitamin B Complex Tablets N.F.I | S0018/2 4-25 | Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol. | Drugs Testing Laboratory Thiruvananthapuram | ||
40. | Vitamin B Complex Tablets N.F.I | S0017/2 4-25 | Kerala Medical Services Corporation Ltd, Thycaud P.O, Thiruvananthapuram-14 | The sample does not conform to IP standards to Descriptive part for tablets As per IP, the tablets should have sufficient hardness to withstand handling without crumbling or breaking. The tablets are soft and in powdered form and cannot be removed from strip in intact form and further tests cannot be performed for the reason specified in the laboratory protocol. | Drugs Testing Laboratory ThiruvananthapuramH20 |
41. | Asokarishtam | 56 | 09/24 | Within 3 Yrs from the date of Mfg. | Sakthi Ayurveda Pharmaceuticals, Ottasekharamangalam, Neyyattinkara, Thiruvananthapuram | It fails the test ‘Total Solids’ , ‘Specific Gravity’, ‘Reducing Sugar’ and ‘Alcohol Content’ as specified in the Laboratory protocol as per API | Drugs Testing Laboratory Thiruvananthapuram |
42. | Amrutharishtam | 58 | 09/24 | 3 Yrs from the date of Mfg. | Sakthi Ayurveda Pharmaceuticals, Ottasekharamangalam, Neyyattinkara, Thiruvananthapuram | It fails the test ‘Total Solids’ , ‘Specific Gravity’, ‘Reducing Sugar’ and ‘Alcohol Content’ as specified in the Laboratory protocol as per API | Drugs Testing Laboratory Thiruvananthapuram |
43. | Balarishtam | 57 | 09/24 | NO EXPIRY | Sakthi Ayurveda Pharmaceuticals, Ottasekharamangalam, Neyyattinkara, Thiruvananthapuram | It fails the test ‘Total Solids’ , ‘Specific Gravity’, ‘Reducing Sugar’ and ‘Alcohol Content’ as specified in the Laboratory protocol as per API | Drugs Testing Laboratory Thiruvananthapuram |
44. | CEFIXIME & LACTIC ACID BACILLUS TABLETS (AFIX- L 200) | MDP – 785 | Oct-24 | Sep-26 | M/s. MEDINOK HEALTHCARE PVT. LTD., R.S.No. 2/1, Plot No. 87,88,89, Vazhudhavur Main Road, Kurumbapet, Puducherry – 605 009. | For the received sample Cefixime & Lactic Acid Bacillus tablets (AFIX- L 200), The label on the secondary packaging, name of the colour information is concealed ,whereas the primary packaging label specifies ‘Red oxide of Iron’ as the colour. This discrepancy indicates a mismatch between the primary and secondary packaging labels. The primary packaging label claims the tablet colour is ‘ Red oxide of Iron’ but physical verification of the tablet observed as pale yellow colour. – NSQ | Puducherry |
45. | PREGABALIN AND METHYLCOBALA MIN CAPSULES (Amalin Plus ) | MDP- 774 | Oct-24 | Sep-26 | M/s. MEDINOK HEALTHCARE PVT. LTD., R.S.No. 2/1, Plot No. 87,88,89, Vazhudhavur Main Road, Kurumbapet, Puducherry – 605 009. | The sample received is labelled as PREGABALIN AND METHYLCOBALAMIN CAPSULES, however PREGABALIN AND METHYLCOBALAMIN CAPSULES is an official IP monograph (2022) hence should be labelled as PREGABALIN AND METHYLCOBALAMIN CAPSULES IP- Misbranded | Puducherry |
46. | CALCIUM WITH VITAMIN D3 TABLETS IP (S- CAL) | ST2406 09 | Jun-24 | Nov-25 | M/s. Spycaa Life care Sciences Private Limited, No. 253/4C, Thiruvandavar Village, Sirupinayur Panchayat, Uthiramerur Taluk, Kancheepuram District, Pin-603 308 | For the received sample, label is mentioned as “Approved colour used” but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drug Rule,1945 was not mentioned.-Misbranded | Puducherry |
47. | RABEPRAZOLE ENTERIC COATED TABLETS IP 20mg (Rabelanz-20) | SP/T/76 2 | Jun-24 | May-26 | M/s Signoret Pharmaceuticals Pvt.Ltd., Plot No. 556, Industrial area, Phase IX, SAS Nagar-160059 | For the received sample Rabeprazole Enteric Coated Tablets IP 20mg, Chipping and Rough surface defect was observed which should not be present as per Drugs & Cosmetics (Amendment) Act, 2008 of DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No. (V) Chipping and (Vii) Rough surface. Cracking of the coating defect was observed which should not be present as prescribed under rule 124B of the Drugs Rules ,1945. The label is mentioned as ‘Approved colour used’ but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules ,1945 was not mentioned. Does not comply with respect to test for Disintegration and Assay –NSQ | Puducherry |
48. | PANTOPROZOL E SODIUM (EC) & DOMPERIDONE (SR) CAPSULES (Tonixpro DSR) | MDP- 345 | Jul-24 | Jun-26 | M/s. Medinok Healthcare Pvt. Ltd., R.S.No. 2/1, Plot No. 87, 88, 89, Vazhudhavur Main Road, Kurumbapet, Puducherry – 605 009. | The primary packaging label claims ‘Each film coated tablet contains:’ however, on physical observation the received sample is found to be ‘Hard Gelatin Capsules’. The received sample is labelled as ‘PANTOPROZOLE SODIUM (EC) & DOMPERIDONE (SR) CAPSULES’, however Pantoprazole Gastro- resistant and Domperidone Prolonged-release Capsules is an official IP monograph (2022) hence should be labelled as PANTOPRAZOLE SODIUM (EC) & DOMPERIDONE (SR) CAPSULES IP. The sample name and the label claim of the drug states ‘PANTOPROZOLE’ instead of ‘PANTOPRAZOLE’ but the proper name of the drug should be written as prescribed under 96(1), (i)(A) of the Drugs & Cosmetics Act.– Misbranded | Puducherry |
49. | TELMISARTAN & HYDROCHLORO THIAZIDE TABLETS IP (Lanztel-H) | RHT24- 401 | Jul-24 | Jun-26 | M/s Revantis Healthcare, Plot No. 124, HPSIDC, Industrial Area, Baddi, Distt. Solan (H.P)-173205 | For the received sample Telmisartan & Hydrochlorothiazide Tablets IP, Presence of Spot and Rough Surface was observed which should not be present as per Drugs & Cosmetics (Amendment) Act, 2008 of DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No. (i) Presence of Spot/discoloration (vii) Rough surface and rule 124B of the Drugs Rules,1945. –NSQ | Puducherry |
50. | ACECLOFENAC & PARACETAMOL TABLETS (ACPON-P) | ACP- 046 | Aug-24 | Jul-27 | M/s Rippon Laboratories No.44-45, Palaniappa Nagar, Othiyampet, Villianur commune, Puducherry-605 110 | The sample received is labelled as ACECLOFENAC & PARACETAMOL TABLETS (ACPON-P), however ACECLOFENAC & PARACETAMOL TABLETS is an official IP monograph (Addendum 2024) hence should be labelled as ACECLOFENAC & PARACETAMOL TABLETS IP.– Misbranded | Puducherry |
51. | TELMISARTAN TABLETS IP 40 mg (Leaftel-40) | 240390 | Mar-24 | Feb-26 | M/s. Sai sarvaa Biotech Pvt. Ltd., Plot No. 8 & 9, Balaji Nagar, Pattanur, Auroville (PO), Vanur(Tk), Villupuram (Dt), Pin – 605 101. | For the received sample Telmisartan Tablets IP 40 mg (Leaftel-40), Capping defect was observed which should not be present as per Drugs & Cosmetics (Amendment) Act, 2008 of DCC Guidelines on Not Of Standard Quality (NSQ) Drugs Approved in 1993 (Annexure A) Tablets vide serial No. (VI) Capping and rule 124B of the Drugs Rules,1945.- NSQ | Puducherry |
52. | SITAGLIPTIN IP 100mg TABLETS (LanZsita 100) | SP/T/83 8 | Jul-24 | Jun-26 | M/s Signoret Pharmaceuticals Pvt.Ltd., Plot No. 556, Industrial Area, Phase IX, SAS Nagar-160059 | For the received sample Sitagliptin IP 100mg Tablets (LanZsita 100), The label is mentioned as ‘Approved colour used’ but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules ,1945 was not mentioned.- Misbranded | Puducherry |
53. | METHYLCOBALA MIN, FOLIC ACID, ALPHA LIPOIC ACID, VITAMIN B6, CHROMIUM PICOLINATE, SODIUM SELENITE & ZINC SOFT GELATIN CAPSULES (Mi- 6) | SOD- 2470 | May-24 | Apr-26 | M/s. Symbiosis Pharmaceuticals Pvt. Ltd., At C/o Ovation Remedies Behind IITT Engg. College, Trilokpur Road, Kala Amb. Distt. Sirmour, HP – 173030 | Does not comply with respect to test for Disintegration –NSQ | Puducherry |
54. | SITAGLIPTIN PHOSPHATE 50 + METFORMIN 500MG TABLETS (LanZsita-M) | SP/T/76 1 | Jun-24 | May-26 | M/s. SIGNORET PHARMACEUTICALS PVT.LTD., Plot No. 556, Industrial area, Phase IX, SAS nagar,-160059. | For the received sample SITAGLIPTIN PHOSPHATE 50 + METFORMIN 500MG TABLETS (LanZsita-M), The label is mentioned as ‘Approved colour used’ but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules,1945 was not mentioned.-Misbranded | Puducherry |
55. | DICLOFENAC SODIUM AND PARACETAMOL TABLETS I.P (DiCLOWiN PLUS) | DPT- 5765 | Aug-24 | Jul-27 | M/s. Wings Biotech LLP, 43 & 44, HPSIDC, Industrial Area, Baddi – 173 205 (H.P) | Does not comply with respect to Assay for Diclofenac sodium –NSQ | Puducherry |
Not of Standard Quality (NSQ) drugs:
The drugs that fail to meet the quality standards or specifications are known as Not of Standard Quality (NSQ) drugs.
(Further, the term ‘standards of quality’ is defined under the Section 16 (1) (a) of Drugs & Cosmetics Act, 1940, that the ‘standards of quality’ mean that the drug complies with the standards set out in the Second Schedule of the said Act.)
NOTE:
Misbranded drugs:
a) if it is so coloured, coated, powdered or polished that damage is concealed or if it is made to appear of better or greater therapeutic value than it really is; or
b) if it is not labelled in the prescribed manner; or
c) if its label or container or anything accompanying the drug bears any statement, design or device which makes any false claim for the drug or which is false or misleading in any particular.
The term “Misbranded Drug” has been defined under Section 17 of the Drugs and Cosmetics Act, 1940.
NOTE:
1.NSQ data received in EXCEL SHEET from State Drugs Licensing Authorities of Puducherry, Kerala, West Bengal, Tripura, Telangana, Jammu Kashmir and Goa (PDF Format), Ladakh (PDF Format), Jharkhand (PDF Format), Himachal Pradesh (PDF Format), Assam(PDF Format), Karnataka (PDF Format), Rajasthan (PDF Format)for the month of February, 2025 as per DCG(I) Circular dated 09.02.2024.
2. State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Bihar, Chhattisgarh, Chandigarh, Gujarat, Haryana, Manipur, Madhya Pradesh, Maharashtra, Meghalaya, Mizoram, Nagaland, Odisha, Punjab, Sikkim, Tamil Nadu, Delhi, Uttarakhand, Uttar Pradesh, Andaman &Nicobar, Dadar and Nagar Haveli, Daman and Diu, Lakshadweep have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of February, 2025 as per DCG(I) Circular dated 09.02.2024.
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos by The Health Master, click on the below YouTube icon:
For informative videos on Medical Store / Pharmacy, click on the below YouTube icon:
For informative videos on the news regarding Pharma / Medical Devices / Cosmetics / Homoeopathy etc., click on the below YouTube icon:
For informative videos on consumer awareness, click on the below YouTube icon: